ACM
RVMD icon

Aster Capital Management’s Revolution Medicines RVMD Stock Holding History

Aster Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,648
Closed -$502K – 1314
2025
Q2 		$502K Buy
+13,648
New +$524K 0.11% 212

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Aster Capital Management's RVMD Position: Q3 2025 in Review

Aster Capital Management sold out of Revolution Medicines (RVMD) in Q3 2025, closing a stake of 13,648 shares — an estimated $502K sold.

Aster Capital Management first reported a position in RVMD in Q2 2025 and held it in 1 quarter. The position peaked at $502K in Q2 2025. 323 funds tracked by Wall St. Rank hold RVMD as of Q3 2025.

  • Aster Capital Management reported no remaining Revolution Medicines position as of Q3 2025 after selling out during the quarter.
  • Aster Capital Management sold 13,648 Revolution Medicines shares in Q3 2025, an estimated $502K.
  • Aster Capital Management first reported a position in Revolution Medicines in Q2 2025 and held it in 1 quarter.
  • Aster Capital Management's Revolution Medicines position peaked at $502K in Q2 2025.
  • 323 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2025.

Based on Aster Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.